No disclosed counterparties: NRDS, PRAA.
| Stage | NRDS | % of rev | PRAA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $197M | 100.00% | $372M | 100.00% | PRAA ×1.89 |
| Gross profit | $184M | 93.21% | $302M | 81.09% | NRDS +12.1pp |
| Operating income | $7M | 3.55% | $153M | 41.19% | PRAA +37.6pp |
| Pre-tax income | $7M | 3.70% | $88M | 23.73% | PRAA +20.0pp |
| Net income | $4M | 2.18% | $59M | 15.84% | PRAA +13.7pp |
| Stage | NRDS | PRAA | Gap · A − B |
|---|---|---|---|
| Revenue | $197M100.00% | $372M100.00% | PRAA ×1.89 |
| Gross profit | 93.21%$184M | 81.09%$302M | NRDS +12.1pp |
| Operating income | 3.55%$7M | 41.19%$153M | PRAA +37.6pp |
| Pre-tax income | 3.70%$7M | 23.73%$88M | PRAA +20.0pp |
| Net income |
| 2.18%$4M |
| 15.84%$59M |
| PRAA +13.7pp |